Compounded GLP-1s: Filling a Medical Need But Posing What Dangers?
There are many drugs on the market created in a myriad of ways with some manufacturing processes less regulated, and therefore more dangerous, than others. One such method is called human drug compounding. Compounding occurs when a licensed physician or person under the supervision of a licensed pharmacist combines ingredients […]
The Unfinished Cleanup: PFAS in the Anacostia
Rivers running around Washington, D.C. are no stranger to contamination. Aging combined sewer systems routinely dump wastewater into local waterways through discharges known as combined sewage overflows, while legacy pollution from past military activities pollute the water as well, particularly in the Anacostia. D.C.’s agencies have evolved to address the […]
Deregulating the EPA: How the Elimination of the Endangerment Finding Ignores Health Consequences for Infants and Children
This month, the Environmental Protection Agency (EPA) under the Trump administration rescinded the Obama-era Greenhouse Gas (GHG) Endangerment Finding and the subsequent emission regulation standards that have accompanied it. Published by the EPA on December 15, 2009, the Endangerment and Cause or Contribute Findings for Greenhouse Gases Under Section 202(a) […]
Recent Bipartisan Report Raises Concerns About Incarceration of Juveniles with Mental Health Needs
The offices of Democratic Senator Jon Ossoff of Georgia and Republican Representative Jen Kiggans of Virginia have released a seminal report after conducting a more than year-long investigation into the prolonged incarceration of children with mental health conditions. They found that more than half of the surveyed juvenile detention centers […]
Can TrumpRx Beat Big Pharma at Its Own Game?
On February 5, 2026, the Trump administration launched trumprx.gov, a government-linked prescription drug website intended to help Americans access discounted prescription medicines. The platform was unveiled by the Administration as part of a broader effort to make drug prices more affordable for U.S. patients. Rather than functioning as a traditional […]
